Literature DB >> 17029127

Outbreak of cutaneous Rhizopus arrhizus infection associated with karaya ostomy bags.

Mysheika LeMaile-Williams1, Lauren A Burwell, Diane Salisbury, Judith Noble-Wang, Matt Arduino, Tim Lott, Mary E Brandt, Sondra Iiames, Arjun Srinivasan, Scott K Fridkin.   

Abstract

BACKGROUND: We investigated an outbreak involving 2 patients hospitalized at hospital A with cutaneous Rhizopus arrhizus (oryzae) infections of surgically created stomas.
METHODS: A cohort study involving all patients having ileostomy or colostomy surgery during the outbreak period (January-April 2005) was performed. Environmental samples, including samples obtained from nonsterile karaya (a plant-derived adhesive) ostomy bags and from select hospital areas, were collected. A point prevalence survey was conducted at 5 unrelated hospitals to assess stoma care practices and mold contamination of karaya ostomy bags outside of hospital A. Zygomycete isolates were identified by standard methods.
RESULTS: Infections occurred 7 and 10 days after operations for the 2 patients; 1 patient died. In a 21-patient cohort, receiving the equivalent of > or =0.5 mg/kg per day of prednisone during the week prior to the index date was associated with infection (infection rate, 33% for patients receiving > or =0.5 mg/kg per day of prednisone vs. 0% for patients receiving <0.5 mg/kg per day of prednisone; P=.07). The time to first ostomy bag change was longer for patients with infection (median duration, 8.5 days; range, 7-10 days) than for the 19 patients without infection (median duration, 1.5 days; range, 1-17 days; P=.08). At unrelated hospitals, the median time to first ostomy bag change was 2 days (range, 1-6 days) for 18 patients after ostomy. R. arrhizus was recovered from 10 of 18 karaya ostomy bags from hospital A and from karaya ostomy bags donated from 3 of 5 other hospitals, but it was not recovered from the hospital A environment.
CONCLUSIONS: The initial karaya ostomy bag was likely to be the source of Rhizopus infection, and prolonged exposure before the first ostomy bag change might have precipitated infection in these susceptible individuals. Karaya might contain opportunistic molds that can pose an infectious risk among susceptible persons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17029127     DOI: 10.1086/508277

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

Review 1.  Hospital-related outbreaks due to rare fungal pathogens: a review of the literature from 1990 to June 2011.

Authors:  E C Repetto; C G Giacomazzi; F Castelli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-03       Impact factor: 3.267

2.  Rapidly progressive cutaneous Rhizopus microsporus infection presenting as Fournier's gangrene in a patient with acute myelogenous leukemia.

Authors:  C M Durand; C D Alonso; A P Subhawong; N P Kwiatkowski; M Showel; K C Carroll; K A Marr
Journal:  Transpl Infect Dis       Date:  2011-03-28       Impact factor: 2.228

3.  Cutaneous mucormycosis following COVID-19 Vaccination in a Bullous Pemphigoid Patient.

Authors:  Kishan M Shah; Cameron West; Jana Simpson; Yevgeniya B Rainwater
Journal:  JAAD Case Rep       Date:  2021-06-26

4.  Seasonal clustering of sinopulmonary mucormycosis in patients with hematologic malignancies at a large comprehensive cancer center.

Authors:  Shobini Sivagnanam; Dhruba J Sengupta; Daniel Hoogestraat; Rupali Jain; Zach Stednick; David N Fredricks; Paul Hendrie; Estella Whimbey; Sara T Podczervinski; Elizabeth M Krantz; Jeffrey S Duchin; Steven A Pergam
Journal:  Antimicrob Resist Infect Control       Date:  2017-12-06       Impact factor: 4.887

Review 5.  A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare.

Authors:  Kathleen P Hartnett; Brendan R Jackson; Kiran M Perkins; Janet Glowicz; Janna L Kerins; Stephanie R Black; Shawn R Lockhart; Bryan E Christensen; Karlyn D Beer
Journal:  J Fungi (Basel)       Date:  2019-07-24

6.  Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to Rhizopus arrhizus (Syn. R. oryzae), the Principal Global Agent of Mucormycosis in Humans.

Authors:  Genna E Davies; Christopher R Thornton
Journal:  J Fungi (Basel)       Date:  2022-07-21

Review 7.  COVID-19-associated mucormycosis: A review of an emergent epidemic fungal infection in the era of COVID-19 pandemic.

Authors:  Vinay Chamola; Rasoul Mohammadi; Harish Nair; Adit Goyal; Aarya Patel; Vikas Hassija; Matteo Bassetti; Pratik Narang; Roger Paredes; Jose R Santos; Seyed Jamal Hashemi; Mahnaz Pejman Sani; Kiana Shirani; Neda Alijani; Bahareh Abtahi Naeini; Mohsen Pourazizi; Seyed Hamidreza Abtahi; Farzin Khorvash; Mahdi Khanjari; Kazem Ahmadikia
Journal:  J Res Med Sci       Date:  2022-07-29       Impact factor: 1.985

Review 8.  Epidemiology and Diagnosis of Mucormycosis: An Update.

Authors:  Anna Skiada; Ioannis Pavleas; Maria Drogari-Apiranthitou
Journal:  J Fungi (Basel)       Date:  2020-11-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.